Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults

NCT01879163 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis (TB)

Interventions

BIOLOGICAL: MVA85A-IMX313
BIOLOGICAL: MVA85A

Sponsor

University of Oxford

Collaborators

[object Object]